A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer’s therapies and the road ahead.
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Study demonstrates that additional proteins misfold in the presence of neurodegenerative disease pathologies.
Following Sandra Day O’Connor’s announcement of her dementia, and possibly Alzheimer’s, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
A mouse-model study led by Drs. Paramita Chakrabarty and Todd Golde describes how their team bioengineered a naturally occurring protein to enable it to bind to amyloid beta protein in the brain.
MBI members discuss how the service and science hub specialty care model is working at the Fixel Center.
The vulnerability of particular brain regions in old age that are important for problem-solving and reasoning.
Glenn Smith, Ph.D., ABPP-cn, chair of the department of clinical and health psychology, recently commented on the state of Alzheimer’s disease research in a Citrus County Chronicle feature story.
Visit Drs. Todd Golde and Brenda Moore’s Reddit Science AMA from Jan. 31, where they answered questions about the future of Alzheimer’s research.